Home
Chemicals

Sector: Chemicals

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

Nanoco eyeing further assertions following big-money Samsung pay-out, says CEO

Brian Tenner sits down with IAM to discuss the company’s win and future strategy

The fast-evolving cannabis patent dispute landscape

GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation

Latest content

Pfizer gets boost in landmark $1 billion pregabalin patent damages dispute

UK court sides with the drug company on key counterfactual assumptions in high-stakes compensation battle with the NHS and generics

03 August 2021

Leading Chinese EV battery maker goes on patent attack against upstart rival

CATL sees injunction opportunity as competition among domestic players heats up

30 July 2021

Delhi High Court ruling against AstraZeneca could spell trouble for pharma innovators

A recent decision puts selection drug patents in jeopardy

29 July 2021

Expect court battles over tougher US pay-for-delay scrutiny

The FTC is likely to make new rules on reverse-payment settlements, but there could be significant pushback

27 July 2021

Genentech’s troubles highlight biosimilar trade secret risks

Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges

23 July 2021

Biopharma M&A has fallen off a cliff – but IP owners in the sector have reasons to be cheerful

The number and value of acquisitions have both tumbled further than in the early months of 2020

20 July 2021

Biden’s march-in rights reversal is further evidence of US policy shift on pharma IP rights

US president abandons Trump-era proposal to rule out patent suspensions under the Bayh-Dole Act

16 July 2021

China’s patent linkage system is finally up and running

What the final implementing measures of the Hatch-Waxman-style framework mean for biopharma patentees and generics

15 July 2021

New SPC data demonstrates the commercial power of patent extension rights in Europe

A recent report into supplementary protection certificates provides crucial insights for IP strategists and policy-makers

08 July 2021

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement

07 July 2021

Unlock unlimited access to all IAM content